Oslo, 11. November 2021 – Navamedic ASA (OSE: NAVA) today announces it has entered into a market making agreement with Norne Securities AS. The purpose of the agreement is to enhance liquidity in the trading of the company’s shares, which are listed on Oslo Stock Exchange. The agreement is in accordance with the standard requirements of Oslo Stock Exchange. First day of market making will be Friday, 12. November 2021.
For further information, please contact:
Lars Hjarrand, CFO, Navamedic
Mobile: +47 917 62 842
Navamedic ASA is a Nordic pharma company and reliable provider of high-quality products, delivered to hospitals and through pharmacies, meeting the specific needs of patients and consumers by leveraging its highly scalable market access platform, leading category competence and local knowledge. Navamedic is present in all the Nordic countries, the Baltics and Benelux, with sales representation in the UK and Greece. Navamedic is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange (ticker: NAVA). For more information, please visit www.navamedic.com